前立腺肥大症に対するCerniltonの臨床評価

概要

論文の詳細を見る
前立腺肥大症の20例にCernilton(R)を1日6錠平均13.2週投与した.1)自覚症状の改善は残尿感92%,遷延性排尿86%,夜間排尿回数85%,排尿時のいきみ56%,苒延性排尿53%,尿線の勢い53%であった.総合効果では80%が中等度改善以上であった.2)他覚所見の総合効果は54%が中等度改善以上で,夜間排尿回数,残尿量,排尿量が有意に改善した.3)総合効果では80%が有効以上であった.4)副作用は全く認められなかったTwenty patients with benign prostatic hypertrophy were treated with Cernilton, 6 tablets a day for an average of 13.2 weeks. Subjective effectiveness was observed in the improvement of sense of residual urine (92%), retardation (86%), night frequency (85%), strain on urination (56%), protraction (53%) and forceless urinary stream (53%). The overall subjective effectiveness was 80% of patients, and the overall objective effectiveness was 54% of patients. Night frequency, residual urine volume and tidal urine volume were improved significantly. The overall effectiveness was 80%. No side effects were observed.